Human stanniocalcin-1 suppresses angiotensin II-induced superoxide generation in cardiomyocytes through UCP3-mediated anti-oxidant pathway

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Liu, Dajun ^a,d   Huang, Luping ^a   Wang, Yanlin ^a   Wang, Wei ^a   Wehrens, Xander H T ^a   Belousova, Tatiana ^a   Abdelrahim, Maen ^b   DiMattia, Gabriel ^c   Sheikh Hamad, David ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b M D ANDERSON CANCER CENTER ORLANDO   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANGIOTENSIN II; CYTOCHROME C OXIDASE; HYPOCALCIN; NEUROHORMONE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); STANNIOCALCIN 1; SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 3; ANTIOXIDANT; GLYCOPROTEIN; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 3; SUPEROXIDE;

ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BIOSYNTHESIS; CELL ISOLATION; CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE CELL; HORMONAL REGULATION; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION UNCOUPLING; PROTEIN FUNCTION; RESPIRATORY CHAIN; ANIMAL; CYTOLOGY; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; MITOCHONDRION; TRANSGENIC MOUSE; UPREGULATION;

RATTUS;

ADENOSINE TRIPHOSPHATE; ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; GLYCOPROTEINS; HUMANS; ION CHANNELS; MICE; MICE, TRANSGENIC; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MYOCYTES, CARDIAC; SUPEROXIDES; UP-REGULATION;

EID: 84861716974     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036994     Document Type: Article

References (48)

1. Sheikh-Hamad D, Bick R, Wu GY, Christensen BM, Razeghi P, et al. (2003) Stanniocalcin-1 is a naturally occurring L-channel inhibitor in cardiomyocytes: relevance to human heart failure. Am J Physiol Heart Circ Physiol 285: H442-H448.
2. Varghese R, Wong CK, Deol H, Wagner GF, DiMattia GE, (1998) Comparative analysis of mammalian stanniocalcin genes. Endocrinology 139: 4714-4725.
3. Re RN, Cook JL, (2010) The mitochondrial component of intracrine action. Am J Physiol Heart Circ Physiol 299: H577-H583.
4. Jellinek DA, Chang AC, Larsen MR, Wang X, Robinson PJ, et al. (2000) Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cells. Biochem J 350 Pt 2: 453-461.
5. Luo CW, Kawamura K, Klein C, Hsueh AJ, (2004) Paracrine regulation of ovarian granulosa cell differentiation by stanniocalcin (STC) 1: mediation through specific STC1 receptors. Mol Endocrinol 18: 2085-2096.
6. McCudden CR, James KA, Hasilo C, Wagner GF, (2002) Characterization of mammalian stanniocalcin receptors. Mitochondrial targeting of ligand and receptor for regulation of cellular metabolism. J Biol Chem 277: 45249-45258.
7. Sazonova O, James KA, McCudden CR, Segal D, Talebian A, et al. (2008) Stanniocalcin-1 secretion and receptor regulation in kidney cells. Am J Physiol Renal Physiol 294: F788-F794.
8. James K, Seitelbach M, McCudden CR, Wagner GF, (2005) Evidence for stanniocalcin binding activity in mammalian blood and glomerular filtrate. Kidney Int 67: 477-482.
9. Huang L, Garcia G, Lou Y, Zhou Q, Truong LD, et al. (2009) Anti-inflammatory and renal protective actions of stanniocalcin-1 in a model of anti-glomerular basement membrane glomerulonephritis. Am J Pathol 174: 1368-1378.
10. Westberg JA, Serlachius M, Lankila P, Andersson LC, (2007) Hypoxic preconditioning induces elevated expression of stanniocalcin-1 in the heart. Am J Physiol Heart Circ Physiol 293: H1766-H1771.
11. Ellard JP, McCudden CR, Tanega C, James KA, Ratkovic S, et al. (2007) The respiratory effects of stanniocalcin-1 (STC-1) on intact mitochondria and cells: STC-1 uncouples oxidative phosphorylation and its actions are modulated by nucleotide triphosphates. Mol Cell Endocrinol 264: 90-101.
12. Varghese R, Gagliardi AD, Bialek PE, Yee SP, Wagner GF, et al. (2002) Overexpression of human stanniocalcin affects growth and reproduction in transgenic mice. Endocrinology 143: 868-876.
13. Filvaroff EH, Guillet S, Zlot C, Bao M, Ingle G, et al. (2002) Stanniocalcin 1 alters muscle and bone structure and function in transgenic mice. Endocrinology 143: 3681-3690.
14. Clapham JC, Arch JR, Chapman H, Haynes A, Lister C, et al. (2000) Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature 406: 415-418.
15. Thompson MP, Kim D, (2004) Links between fatty acids and expression of UCP2 and UCP3 mRNAs. FEBS Lett 568: 4-9.
16. Wang Y, Huang L, Abdelrahim M, Cai Q, Truong A, et al. (2009) Stanniocalcin-1 suppresses superoxide generation in macrophages through induction of mitochondrial UCP2. J Leukoc Biol 86: 981-988.
17. Jiang N, Zhang G, Bo H, Qu J, Ma G, et al. (2009) Upregulation of uncoupling protein-3 in skeletal muscle during exercise: a potential antioxidant function. Free Radic Biol Med 46: 138-145.
18. Murray AJ, Anderson RE, Watson GC, Radda GK, Clarke K, (2004) Uncoupling proteins in human heart. The Lancet 364: 1786-1788.
19. Kim-Han JS, Dugan LL, (2005) Mitochondrial uncoupling proteins in the central nervous system. Antioxid Redox Signal 7: 1173-1181.
20. Brand MD, Esteves TC, (2005) Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. Cell Metab 2: 85-93.
21. Rousset S, Alves-Guerra MC, Mozo J, Miroux B, Cassard-Doulcier AM, et al. (2004) The Biology of Mitochondrial Uncoupling Proteins. Diabetes 53: S130-S135.
22. Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning BS, et al. (2000) Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 26: 435-439.
23. Sack MN, (2006) Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance. Cardiovasc Res 72: 210-219.
24. Korshunov SS, Skulachev VP, Starkov AA, (1997) High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 416: 15-18.
25. Sorescu D, Griendling KK, (2002) Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congest Heart Fail 8: 132-140.
26. Mohazzab H, Kaminski PM, Wolin MS, (1997) Lactate and PO2 modulate superoxide anion production in bovine cardiac myocytes: potential role of NADH oxidase. Circulation 96: 614-620.
27. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, et al. (1995) Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11: 376-381.
28. Wu S, Gao J, Ohlemeyer C, Roos D, Niessen H, et al. (2005) Activation of AP-1 through reactive oxygen species by angiotensin II in rat cardiomyocytes. Free Radic Biol Med 39: 1601-1610.
29. Sheikh-Hamad D, (2010) Mammalian stanniocalcin-1 activates mitochondrial antioxidant pathways: new paradigms for regulation of macrophages and endothelium. Am J Physiol Renal Physiol 298: F248-F254.
30. Razeghi P, Young ME, Alcorn JL, Moravec CS, Frazier OH, et al. (2001) Metabolic gene expression in fetal and failing human heart. Circulation 104: 2923-2931.
31. Razeghi P, Young ME, Ying J, Depre C, Uray IP, et al. (2002) Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading. Cardiology 97: 203-209.
32. Taegtmeyer H, (2002) Switching metabolic genes to build a better heart. Circulation 106: 2043-2045.
33. Fosslien E, (2003) Review: Mitochondrial medicine-cardiomyopathy caused by defective oxidative phosphorylation. Ann Clin Lab Sci 33: 371-395.
34. Beer M, Seyfarth T, Sandstede J, Landschutz W, Lipke C, et al. (2002) Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol 40: 1267-1274.
35. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, et al. (1997) Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96: 2190-2196.
36. Vidal-Puig AJ, Grujic D, Zhang CY, Hagen T, Boss O, et al. (2000) Energy metabolism in uncoupling protein 3 gene knockout mice. J Biol Chem 275: 16258-16266.
37. Cline GW, Vidal-Puig AJ, Dufour S, Cadman KS, Lowell BB, et al. (2001) In vivo effects of uncoupling protein-3 gene disruption on mitochondrial energy metabolism. J Biol Chem 276: 20240-20244.
38. Elkayam U, (1998) Calcium channel blockers in heart failure. Cardiology 89 (Suppl 1): 38-46.
39. Zhang J, Alfonso P, Thotakura NR, Su J, Buergin M, et al. (1998) Expression, purification, and bioassay of human stanniocalcin from baculovirus-infected insect cells and recombinant CHO cells. Protein Expr Purif 12: 390-398.
40. Gong DW, Monemdjou S, Gavrilova O, Leon LR, Marcus-Samuels B, et al. (2000) Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3. J Biol Chem 275: 16251-16257.
41. Jacobsen SL, (1989) Techniques for isolation and culture of adult cardiomyocytes. In: Piper HM, editors. Isolated Adult Cardiomyocytes: Structure and function Boca Raton CRC Press pp. 43-82.
42. Poindexter BJ, Smith JR, Buja LM, Bick RJ, (2001) Calcium signaling mechanisms in dedifferentiated cardiac myocytes: comparison with neonatal and adult cardiomyocytes 4. Cell Calcium 30: 373-382.
43. Lu Z, Jiang YP, Wang W, Xu XH, Mathias RT, et al. (2009) Loss of cardiac phosphoinositide 3-kinase p110 alpha results in contractile dysfunction. Circulation 120: 318-325.
44. Nohl H, (1987) A novel superoxide radical generator in heart mitochondria. FEBS Lett 214: 269-273.
45. Saks VA, Kuznetsov AV, Kupriyanov VV, Miceli MV, Jacobus WE, (1985) Creatine kinase of rat heart mitochondria. The demonstration of functional coupling to oxidative phosphorylation in an inner membrane-matrix preparation. J Biol Chem 260: 7757-7764.
46. Wiedemann FR, Manfredi G, Mawrin C, Beal MF, Schon EA, (2002) Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J Neurochem 80: 616-625.
47. Sottocasa GL, Kuylenstierna B, Ernster L, Bergstrand A, (1967) An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study. J Cell Biol 32: 415-438.
48. Sherratt HS, Watmough NJ, Johnson MA, Turnbull DM, (1988) Methods for study of normal and abnormal skeletal muscle mitochondria. Methods Biochem Anal 33: 243-335.